Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modular extracorporeal liver support.

Igor M Sauer1, Joerg C Gerlach

  • 1Charité--Campus Virchow, Allgemein-, Visceral-, und Transplantationschirugie, Charité Institute for Transplantation and Organ Regeneration, CITO, Berlin, Germany. igor.sauer@charite.de

Artificial Organs
|July 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation of functional human islets from pancreatectomy remnants: Determinants of yield and functionality.

Cell transplantation·2026
Same author

Biomimetic characterization by micro-computed tomography (μCT) of 3D hollow fibre membrane network bioreactors for tissue engineering.

Biomaterials science·2026
Same author

Compact Tabletop Magnetic Resonance Elastography for Mapping Soft Tissue Viscoelasticity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Author Correction: Injured epithelial cell states impact kidney allograft survival after T-cell-mediated rejection.

Nature communications·2026
Same author

Proteomic profiling of colorectal liver metastases reveals histopathological response-specific molecular signatures of chemotherapy efficacy.

Journal of translational medicine·2026
Same author

Impact of Donor Age and Prolonged Warm Ischemia in Normothermic Machine Perfusion of Rat Livers.

Tissue engineering. Part A·2026
Same journal

Large-Eddy Simulation of the FDA Benchmark Blood Pump: Validation Against Experiments and Implications for Turbulent Flow Mechanisms.

Artificial organs·2026
Same journal

The Warm Revolution: A Meta-Analysis of DCD Versus DBD Liver Transplant Outcomes in the Normothermic Machine Perfusion Era.

Artificial organs·2026
Same journal

Toward Optimal Remote Monitoring in LVAD Recipients: Remaining Challenges Beyond Feasibility.

Artificial organs·2026
Same journal

Advancing Organ Preservation and Perfusion: Introducing the International Society of Organ Preservation and Perfusion Therapy (ISOPPT).

Artificial organs·2026
Same journal

Short Inter-Treatment Interval Treatment With Artificial Liver Support System Reduces 90-Day Transplant-Free Mortality in Patients With Hepatitis B Virus-Related Acute-On-Chronic Liver Failure: A Retrospective Observational Study.

Artificial organs·2026
Same journal

Extracorporeal Albumin Dialysis (OPAL) as Novel Therapeutic Bridging Option in Posthepatectomy Liver Failure.

Artificial organs·2026
See all related articles

Modular extracorporeal liver support (MELS) offers a flexible approach to treating liver failure. This system uses a bioreactor with human liver cells and albumin dialysis to reduce toxins and support liver function.

Area of Science:

  • Biomedical Engineering
  • Hepatology
  • Regenerative Medicine

Background:

  • Hepatic failure presents a critical unmet medical need.
  • Current treatments for liver failure have limitations.
  • Extracorporeal liver support systems aim to bridge patients to recovery or transplantation.

Purpose of the Study:

  • To introduce the concept and components of Modular Extracorporeal Liver Support (MELS).
  • To describe the function of the CellModule and DetoxModule within the MELS system.
  • To outline the potential application of the DialysisModule for hepatorenal syndrome.

Main Methods:

  • The MELS system integrates modular extracorporeal therapy units.
  • The CellModule utilizes a bioreactor with primary human liver cells from non-transplantable donor livers.

Related Experiment Videos

  • The DetoxModule employs albumin dialysis to remove toxins and support cellular function.

    • Main Results:

    • The CellModule provides a biological component for liver support.
    • The DetoxModule reduces the biochemical burden on liver cells.
    • The system is adaptable, with an optional DialysisModule for comprehensive support.

    Conclusions:

    • Modular Extracorporeal Liver Support (MELS) offers a customizable approach to hepatic failure treatment.
    • The combination of bioartificial liver support and detoxification modules presents a promising therapeutic strategy.
    • Further clinical evaluation is warranted to establish the efficacy of MELS in patients with liver failure.